Pharma-Bio Serv (PBSV) Short-term Investments (2010 - 2026)

Pharma-Bio Serv's Short-term Investments history runs 12 years deep, the most recent figure standing at $6.7 million for Q2 2026.

• Short-term Investments for Q2 2026 came in at $6.7 million, down 19.64% year-over-year; the trailing twelve-month figure through Apr 2026 was $6.7 million (down 19.64% YoY), and the FY2025 annual result was $7.5 million, up 25.05% from the prior year.
• Short-term Investments came in at $6.7 million for Q2 2026 at Pharma-Bio Serv, up from $4.8 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $11.7 million in Q3 2023 to a low of $4.5 million in Q4 2023.
• A 4-year average of $7.2 million and a median of $6.7 million in 2025 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments jumped 80.98% in 2024 and sank 45.89% in 2025, its largest moves.
• Over 4 years, Short-term Investments stood at $4.5 million in 2023, then soared by 31.93% to $6.0 million in 2024, then rose by 25.05% to $7.5 million in 2025, then retreated by 10.63% to $6.7 million in 2026.
• The last three Short-term Investments figures came in at $6.7 million (Q2 2026), $4.8 million (Q1 2026), and $7.5 million (Q4 2025), per Business Quant data.